Thank you for being a part of the NDRI Community. NDRI’s Board of Directors and leadership team has made the decision to postpone our 40th Anniversary Service to Science Dinner in Philadelphia, PA on November 12, 2020, due to growing uncertainty surrounding the current and evolving COVID19 outbreak.
NDRI is proud to announce the second annual NDRI & AOPO Empowering Research and Discovery Award will be presented virtually at the Association of Organ Procurement Organizations - AOPO the week of June 22.
This award recognizes an organ procurement organization committed to advancing research. Nominations will be accepted through June 1, 2020. The NDRI and AOPO Research and Discovery Award will be presented to an organ procurement organization for their work with NDRI and commitment to research broadly. Nominate your OPO here:
In this special edition of NDRI's Research Nexus, learn about the valuable partnerships and programs that have shaped NDRI's 40-year-old mission, how we have grown from supporting diabetes research to serving researchers around the world with tissues and organs for research on multiple diseases, and our plans to celebrate this year's milestone.
The National Disease Research Interchange (NDRI) has been awarded a research grant of $275,000 to continue to support efforts of the National Institutes of Mental Health (NIMH) and the Office of Director of the National Institutes of Health (NIH) aimed at furthering the research of the causes and behavioral associations with individuals diagnosed with Autism Spectrum Disorder (ASD). NDRI has been consistently supported by the NIH to support Autism research since 2016.
We are pleased to announce the relocation of NDRI’s offices! Our new address is:
Three Parkway, 1601 Cherry Street, Suite 1700, Philadelphia PA 19102
NDRI continues to monitor the spread of COVID-19 in the US and the actions being taken by our transplant partners (the federally designated organ procurement organizations), as required or recommended by federal regulatory and oversight bodies including the Eye Bank Association of America, American Association of Tissue Banks, FDA, and CDC.
Thomas J. Bell, MS, PhD promoted to Senior Vice President, Strategic Intiatives and Melissa VonDran, PhD promoted to Vice President, Operations & Director, Biorepository.
Learn more about our leadership: NDRI Executive Management Team
The Board of Directors and staff of the National Disease Research Interchange are thrilled to honor Susan Hockfield, PhD, President Emerita and Professor of Neuroscience, Massachusetts Institute of Technology with our D. Walter Cohen, DDS, Service to Science Award at our 40th Anniversary Service to Science Awards Dinner.
NDRI has partnered with Research!America to administer a poll of the public to gather interest and support of donation of organs and tissues. The poll findings presented strong support for organ and tissue donations to advance discovery, improve health, and save lives.
NDRI has been accepted as a participant in the poster session at the Society for Neuroscience 2019 annual conference in Chicago, IL from October 19-23. We will be presenting on advancing Alzheimer's disease and related dementias research via a multi-pronged human biospecimens collection initiatives.
The Accreditation Committee of the College of American Pathologists (CAP) awarded accreditation the biorepository of the National Disease Research Interchange (NDRI) in Philadelphia, PA based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. NDRI was first accredited by CAP in 2016. Accreditations occur every three years.
Congratulations to The Center for Organ Recovery and Education, otherwise known as CORE, as the recipient of the inaugural NDRI/AOPO Empowering Research and Discovery Award for Outstanding commitment to the advancement of research.
Robert (Bob) Zipperlen, CPA joined NDRI in the spring of 2019 as the Vice President of Administration & CFO.
Read NDRI's 2019 Research Nexus for an exciting update on programs and initiatives, and learn how NDRI investigators are accelerating scientific discoveries!
Pennsylvania Governor Tom Wolf has appointed Bill Leinweber, President and CEO of the National Disease Research Interchange (NDRI), to serve a five-year term as a member of the state’s Organ and Tissue Donation Advisory Committee.
David M. Albert J.D., Director of Strategy, Emerging Business & Venture Capital Group of Cozen O’Connor. Elected on November 2 to a three-year term, Albert will bring his experience and insight to the nation’s leading source of human organs, cells and tissues for research.
NDRI’s Board of Directors met on Friday, November 2, 2018 to review and approve the 2017 audited financial statements, filing of Form 990, year-to-date financial and programmatic performance and NDRI’s 2019 Budget. Our executive staff provided the Board with a detailed overview of our many successful projects and partnerships, and included an update on the current status of NIH appropriations.
NDRI is very pleased to share that after eight years of advocacy efforts by the Center for Organ Recovery and Education (CORE) and the Gift of Life Donor Program of Philadelphia, lawmakers unanimously passed the Donate Life PA Act (SB 180) on Wednesday, October 10, 2018.
Bill Leinweber, President and CEO of National Disease Research Interchange (NDRI) admits that NDRI’s work is complicated, because medical research is complex. For nearly 40 years, NDRI has accepted the challenge of meeting increasing demands of the medical research community, who rely on high-quality, healthy, and diseased biospecimens to conduct lifesaving research.